Group 1: Inflation Trends - The June Consumer Price Index (CPI) in the U.S. rose by 2.7% year-on-year, slightly exceeding expectations of 2.6%, and up from the previous value of 2.4% [1][2] - The core CPI increased by 2.9% year-on-year, meeting expectations but higher than the previous value of 2.8% [1][2] - The overall CPI data indicates a subtle resurgence of inflationary pressures, prompting a reassessment of market expectations regarding inflation [2] Group 2: Housing Market - The housing index increased by 0.2% in June, contributing significantly to the overall index rise [3] - Housing is viewed as a necessity with stable demand, showcasing strong anti-inflation properties [3] - Real estate investments, particularly Real Estate Investment Trusts (REITs), are expected to provide considerable returns due to stable rental income and property appreciation potential [3] Group 3: Energy Sector - The energy index rose by 0.9% in June, with gasoline prices increasing by 1.0% [4] - Over the past year, the energy index has decreased by 0.8%, with gasoline prices down by 8.3% [4] - Long-term opportunities are anticipated in the clean energy sector, driven by increasing global demand for renewable energy sources [4] Group 4: Food Industry - The food index rose by 0.3% in June, with household and away-from-home food prices increasing by 0.3% and 0.4%, respectively [5] - The food sector is characterized by rigid demand, less affected by economic cycles, and is experiencing a shift towards higher quality and safety standards [5] - Companies with brand advantages and those focusing on organic and health food production are expected to thrive in the competitive landscape [5] Group 5: Non-Food and Non-Energy Sectors - The index excluding food and energy rose by 0.2% in June, with a year-on-year increase of 2.9% [6] - Sectors such as home furnishings, healthcare, and entertainment are showing upward trends, while used and new vehicle prices are declining [6] - The healthcare sector remains attractive due to stable demand, especially for innovative pharmaceutical companies and high-end medical service providers [6]